Selective endothelin A receptor antagonism with sitaxentan reduces neointimal lesion size in a mouse model of intraluminal injury

BACKGROUND AND PURPOSE: Endothelin (ET) receptor antagonism reduces neointimal lesion formation in animal models. This investigation addressed the hypothesis that the selective ET(A) receptor antagonist sitaxentan would be more effective than mixed ET(A)(/)(B) receptor antagonism at inhibiting neoin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Pharmacol
Egile Nagusiak: Duthie, Karolina M, Hadoke, Patrick W F, Kirkby, Nicholas S, Miller, Eileen, Ivy, Jessica R, McShane, John F, Lim, Win Gel, Webb, David J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BlackWell Publishing Ltd 2015
Gaiak:
Research Papers
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4439878/
https://ncbi.nlm.nih.gov/pubmed/25598351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13086
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak